Related Experiment Video
Updated: Feb 7, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
Recent advances in ultrasound-targeted nanobubbles combined with cancer immunotherapy: Mechanisms, applications, and
Xueqin Chen1, Lifan Xu2, Chen Chen3
1Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing 400038, China.
Immunotherapy has revolutionized cancer treatment by leveraging the immune system to target tumors. However, its efficacy is often limited by the immunosuppressive tumor microenvironment and the development of resistance, leading to response rates of only 20%-30%. Ultrasound-targeted nanobubbles (UTN) combined with cancer immunotherapy present a promising solution to the limitations of current treatments. By utilizing the mechanical and biological effects of ultrasound, UTN improve drug delivery, reduce systemic toxicity, and modulate immune responses within the tumor microenvironment. Preclinical studies have shown that UTN combined with cancer immunotherapy can significantly increase the use of checkpoint inhibitors, tumor vaccines, and gene-based therapies, resulting in better tumor control. This article reviews the latest advancements, applications, and challenges of UTN combined with cancer immunotherapy, emphasizing the potential of UTN to overcome current therapeutic barriers and providing a forward-looking perspective on its translation into clinical practice.
Immunotherapy has revolutionized cancer treatment by leveraging the immune system to target tumors. However, its efficacy is often limited by the immunosuppressive tumor microenvironment and the development of resistance, leading to response rates of only 20%-30%. Ultrasound-targeted nanobubbles (UTN) combined with cancer immunotherapy present a promising solution to the limitations of current treatments. By utilizing the mechanical and biological effects of ultrasound, UTN improve drug delivery, reduce systemic toxicity, and modulate immune responses within the tumor microenvironment. Preclinical studies have shown that UTN combined with cancer immunotherapy can significantly increase the use of checkpoint inhibitors, tumor vaccines, and gene-based therapies, resulting in better tumor control. This article reviews the latest advancements, applications, and challenges of UTN combined with cancer immunotherapy, emphasizing the potential of UTN to overcome current therapeutic barriers and providing a forward-looking perspective on its translation into clinical practice.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:

